Older adults’ preferred and perceived roles in decision making about palliative chemotherapy: Their decision priorities, and information preferences.
Erin Moth(The University of Sydney), Prunella Blinman(Concord Repatriation General Hospital), Belinda E. Kiely(National Health and Medical Research Council), Hiren Mandaliya(Lake Macquarie Private Hospital), Robert Zielinski, Andrew Martin(Clinica Universidad de Navarra), Vasi Naganathan(The University of Sydney), Christopher Steer(Albury Wodonga Health), Abi Ragunathan(Camden and Campbelltown Hospitals), Florian Honeyball(The University of Sydney), Stephen Della‐Fiorentina(Camden and Campbelltown Hospitals)
Cited by 2
Related Papers
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k
Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes
|Journal of Clinical Epidemiology|2012|1.2k
Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)
|Translational Lung Cancer Research|2019|392
Medication Withdrawal Trials in People Aged 65 Years and Older
|Drugs & Aging|2008|352
High-Risk Prescribing and Incidence of Frailty Among Older Community-Dwelling Men
|Clinical Pharmacology & Therapeutics|2012|309